Faculty Profiles

Michael Perry, MD, M.A.C.P

Professor of Medicine
Director of Clinical trials

Dr. Perry's interests are in cancer clinical trials, especially lung and breast cancer. He is also interested in the myeloproliferative disorders. He heads the Ellis Fischel Cancer Center Clinical Trials Unit which offers 118 different studies for patients with cancer and hematologic disorders. His research interests include: Lung cancer, breast cancer, myeloproliferative diseases, cancer chemotheraphy, and cancer clinical trials.

Board Certification:

Internal Medicine
Hematology
Oncology
Advanced Achievement in Internal Medicine

Society Memberships:

American Medical Association
Boone County Medical Society
Missouri State Medical Society
American College of Physicians - Mastership
Cancer and Leukemia Group B
Missouri Society of Internal Medicine
American Society of Internal Medicine
American Society of Hematology
American Society of Clinical Oncology
American Federation for Clinical Research
Central Society for Clinical Research
American Association for Cancer Research
International Association for the Study of Lung Cancer
Southern Medical Association
Southern Association for Oncology

Medical School

Wayne State University

Internship & Residency

Mayo Graduate School of Medicine

Fellowship

Mayo Graduate School of Medicine

Editorial Boards:

Editor- Proceedings of the American Society of Clinical Oncology, American Society of Clinical Oncology Education Book
Board Member- Seminars in Oncology, Journal of Clinical Oncology
Ad Hoc Editorial Consultant-American Family Physician, Annals of Internal Medicine, Archives of Internal Medicine, Blood, Cancer, Cancer Research, Cancer Treatment Reports, Chest, European Journal of Cancer and Clinical Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute, Lung Cancer, Mayo Clinic Proceedings, Medical and Pediatric Oncology, Neurosurgery, New England Journal of Medicine, Seminars in Oncology

Selected Publications:

Books

Aisner J, Arriagada R, Green MR, Martini N, Perry MC, editors. Comprehensive Textbook of Thoracic Oncology. Williams & Wilkins, 1996.
Perry MC, editor. The Chemotherapy Source Book, Third Edition. Lippincott, Williams & Wilkins, 2001..

Publications:

Sandler A, Gray R, Perry MC, Brahmer J, Schiller J, Dowlati A, Lilenbaum R, Johnson D. Paclitazel-Carboplatin alone or with Bevacizumab for Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 355:2542-2550, December 14, 2006.
Neill, HB, Herndon, JE II, Miller, AAA, Watson, DM, Dandler, AB, Kelly K, Marks, RS, Perry, MC, Ansari, RH, Otterson, G, Ellerton, J, Vokes, EE, Green, MR. Randomized phase II intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factors in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group Trial 9732. J Clin Oncol 23: 3752-3759, 2005
Stupp, R, Monnerat, C, Turrisi, AT, Perry, MC, Leyvraz, S. Small cell lung cancer: State of the art and future perspectives. Lung Cancer 45:105-117, 2004.